Initially, array comparative genomic hybridization (aCGH) copy number was used to characterize the BRCA1-like phenotype and led to the development of a tool to predict breast cancer in patients with a BRCA1 mutation or promoter hypermethylation [10, 11, 18]. The gene discussed is BRCA1; the disease is breast carcinoma.